MX9707073A - Preparaciones de aerosol de prilocaina e hidrofluorocarbono. - Google Patents

Preparaciones de aerosol de prilocaina e hidrofluorocarbono.

Info

Publication number
MX9707073A
MX9707073A MX9707073A MX9707073A MX9707073A MX 9707073 A MX9707073 A MX 9707073A MX 9707073 A MX9707073 A MX 9707073A MX 9707073 A MX9707073 A MX 9707073A MX 9707073 A MX9707073 A MX 9707073A
Authority
MX
Mexico
Prior art keywords
hydrofluorocarbon
prilocaine
aerosol preparations
prilocaine base
liquid
Prior art date
Application number
MX9707073A
Other languages
English (en)
Other versions
MXPA97007073A (es
Inventor
Richard A Henry
Original Assignee
Richard A Henry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27410659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9707073(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/405,930 external-priority patent/US5593661A/en
Priority claimed from US08/408,877 external-priority patent/US5534242A/en
Application filed by Richard A Henry filed Critical Richard A Henry
Publication of MX9707073A publication Critical patent/MX9707073A/es
Publication of MXPA97007073A publication Critical patent/MXPA97007073A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Una base de prilocaína, en forma líquida y de cristal de microbarras, se puede solubilizar dentro de propulsores de hidrofluorocarbono para producir un líquido oleoso estable; la base de prilocaína se puede usar para solubilizar medicamentos adicionales dentro de propulsores de hidrofluorocarbono que no son ordinariamente solubles; la combinacion de base de prilocaína y propulsor de hidrofluorocarbono se puede usar como una aspersion aerosolizada para proveer anestesia topica.
MXPA/A/1997/007073A 1995-03-17 1997-09-17 Preparaciones de aerosol de prilocaina e hidrofluorocarbono MXPA97007073A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08405930 1995-03-17
US08/405,930 US5593661A (en) 1993-03-29 1995-03-17 Lidocaine aerosol anaesthetic
US08/408,877 US5534242A (en) 1994-05-02 1995-03-24 Lidocaine-vasoconstrictor aerosol preparation
US08408877 1995-03-24
US08/435,812 US5589156A (en) 1994-05-02 1995-05-05 Prilocaine and hydrofluourocarbon aerosol preparations
US08435812 1995-05-05

Publications (2)

Publication Number Publication Date
MX9707073A true MX9707073A (es) 1998-08-30
MXPA97007073A MXPA97007073A (es) 1998-11-12

Family

ID=

Also Published As

Publication number Publication date
ES2203676T3 (es) 2004-04-16
PT814793E (pt) 2003-12-31
US5589156A (en) 1996-12-31
AU710600B2 (en) 1999-09-23
DE69629109D1 (de) 2003-08-21
WO1996029066A1 (en) 1996-09-26
LU92402I2 (fr) 2014-05-19
CN1149080C (zh) 2004-05-12
CN1179103A (zh) 1998-04-15
JP4117707B2 (ja) 2008-07-16
BR9607988A (pt) 1999-11-30
EP0814793A1 (en) 1998-01-07
EP0814793B1 (en) 2003-07-16
DK0814793T3 (da) 2003-12-01
ATE245025T1 (de) 2003-08-15
AU4711396A (en) 1996-10-08
JPH11502202A (ja) 1999-02-23
DE69629109T2 (de) 2004-04-15

Similar Documents

Publication Publication Date Title
ES2193186T3 (es) Composiciones medicamentosas en aerosol para la utilizacion con gases propulsores sin cfc.
KR920703011A (ko) 거품상 에어로솔제제
EP0740528A4 (en) GAS-CONTAINING MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS USE
ATE125153T1 (de) Treibmittelzubereitungen.
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
DE69233150D1 (de) Fluorchlorkohlenwasserstoffreie Aerosolformulierungen
MY119074A (en) Pharmaceutical aerosol composition
CA2201120A1 (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
EP1277467A3 (en) Non-chlorofluorocarbon aerosol formulations
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
CA2214436A1 (en) Corticosteroid-containing pharmaceutical composition
MX9702149A (es) Medicamentos.
DK0851753T3 (da) Aerosolpræparater
GB0016876D0 (en) Novel formulation
AU7026800A (en) Pharmaceutical formulation of fluticasone propionate
ES2134634T3 (es) Composiciones farmaceuticas y dispositivos para su administracion.
TR199900379T2 (xx) Klorofluorokarbon i�ermeyen mometazon furoat aerosol form�lasyonlar�.
MX9707073A (es) Preparaciones de aerosol de prilocaina e hidrofluorocarbono.
CA2215680A1 (en) Prilocaine and hydrofluorocarbon aerosol preparations
ES2165498T3 (es) Dispositivo osmotico con carga elevada de farmaco y activacion retardada de administracion de farmaco.
CA2136607A1 (en) Pharmaceutical Powder Composition Containing Non-Ionic Cellulose Ether Derivative and a Chitin-Derived Polymer
KR890009395A (ko) 흡입제
ATE142479T1 (de) Haarpflegemittel
MX9707238A (es) Formulaciones en aerosol de butixocort.